CG Oncology, Inc. Common stock

CG Oncology, Inc. Common stock

CGON · Nasdaq

CG Oncology, Inc. Common stock (CGON) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for CG Oncology, Inc. Common stock in 2026. The next earnings report is expected on November 12, 2026.

Earnings calendar

Next earnings date

12 Nov 2026

In 82 days

EPS estimate

-0.77

Revenue estimate

478.0K

Past earnings

07 Aug 2026
EPS actual
-0.90 (-35.5%)
estimate -0.66
Revenue actual
1.2M (+220.7%)
estimate 360.8K
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
08 May 2026
EPS actual
-0.71 (-27.8%)
estimate -0.56
Revenue actual
1.1M (+139.1%)
estimate 453.0K
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
27 Feb 2026
EPS actual
-0.55 (+8.4%)
estimate -0.60
Revenue actual
2.3M (+410.5%)
estimate 450.5K
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

CG Oncology, Inc. Common stock missed consensus estimates in its latest earnings report, with EPS of USD -0.9 versus an estimate of USD -0.6642, while revenue of USD 1.16 million exceeded estimates by 220.7%. In the prior quarter EPS also missed expectations while revenue similarly beat estimates.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Their product candidate cretostimogene, is initially in clinical development for the treatment of patients with high-risk Non-Muscle Invasive Bladder Cancer who are unresponsive to Bacillus Calmette Guerin (BCG) therapy, the current standard-of-care for high-risk NMIBC.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Arthur Kuan
Employees
113
IPO date
25 Jan 2024
ISIN
US1569441009
Website
cgoncology.com

Frequently asked questions

When does CG Oncology, Inc. Common stock (CGON) next report earnings?

CG Oncology, Inc. Common stock (CGON) is scheduled to report earnings on November 12, 2026.

What was CG Oncology, Inc. Common stock's most recent earnings date?

CG Oncology, Inc. Common stock (CGON) last reported earnings on August 7, 2026.

Where is CG Oncology, Inc. Common stock stock listed?

CG Oncology, Inc. Common stock (CGON) is listed on Nasdaq.